Pharmagreen Biotech Inc. (PHBI)
| Market Cap | 696.83K |
| Revenue (ttm) | 3.00K |
| Net Income (ttm) | -226.26K |
| Shares Out | 663.65M |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 490,911 |
| Average Volume | 689,617 |
| Open | 0.0010 |
| Previous Close | 0.0011 |
| Day's Range | 0.0010 - 0.0011 |
| 52-Week Range | 0.0006 - 0.0047 |
| Beta | 1.78 |
| RSI | 39.20 |
| Earnings Date | May 16, 2025 |
About Pharmagreen Biotech
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products throu... [Read more]
Full Company ProfileFinancial Performance
In 2024, Pharmagreen Biotech's revenue was $3,410, an increase of 13.74% compared to the previous year's $2,998. Losses were -$1.00 million, 76.6% more than in 2023.
Financial StatementsNews
Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its la...
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress
CARSON CITY, NV, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is pleased to announce the continued advancement of its business develo...
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations
CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with SierraSil® He...
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product
CARSON CITY, NV, Feb. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), “Pharmagreen” or the “Company” is pleased to announce that it has completed developm...
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development
CARSON CITY, NV, Sept. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company) is pleased to announce that Ethan Styles has joined the...
PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch
CARSON CITY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company” is pleased to announce that it has developed its first form...
PHBI – Pharmagreen Provides Updates On Its Business Developments Beyond Just Cannabis
CARSON CITY, NV, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company”) is pleased to announce that, while focused on near term...
PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC
CARSON CITY, NV, May 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company”), which provides the highest quality starter plantlets ut...
PHBI - Pharmagreen Biotech Provides Updates on Its Ongoing Business Developments
CARSON CITY, NV, March 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company”) is pleased to report ongoing business developments...
PHBI Pharmagreen Announces Affirmed MOU to Acquire Licensed California Cannabis Company
CARSON CITY, NV, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley Far...
Pharmagreen Biotech Announces Up-Listing to OTCQB Venture Market
Carson City, Nevada--(Newsfile Corp. - December 21, 2021) - Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Canna...
PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market
CARSON CITY, NV, Dec. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD H...
PHBI - Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard
CARSON CITY, Nev., Dec. 9, 2021 /PRNewswire/ -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a second management update form CEO Peter Wojcik.
PHBI - Pharmagreen Announces Revenue Plan For Proprietary Cannabis Tissue Culture Technology
CARSON CITY, Nev., Dec. 2, 2021 /PRNewswire/ -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik.
PHBI - Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of nar...
Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
CARSON CITY, NV, Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a management update from CEO Peter Wojcik. The update is the first ...
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
CARSON CITY, NV, Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that in advance of its entry into the multi-billion dollar C...
Pharmagreen Submits Its Application for Uplisting to the OTCQB Venture Market
Carson City, Nevada--(Newsfile Corp. - November 4, 2021) - Pharmagreen Biotech, Inc. (OTC PINK: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Ca...
Pharmagreen Provides Update on Funding and Acquisition Progress
CARSON CITY, NV, Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to update its shareholders on the company's Regulation A offering and o...
Pharmagreen Signs MOU to Acquire a California Based Cannabis Company
Carson City, Nevada--(Newsfile Corp. - August 12, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company's developments and progress. Our business de...
Pharmagreen Biotech Inc. Discusses Potential Uplisting and Elimination of Convertible Debt with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - June 16, 2021) - The Stock Day Podcast welcomed Pharmagreen Biotech Inc. (OTC Pink: PHBI) ("the Company"), a company focused on the CBD hemp industry for the produc...
Pharmagreen Provides Company Update For Its Shareholders
CARSON CITY, NV, April 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to update its shareholders on the company's developments and progress. ...
Pharmagreen Extends the Letter of Intent Timeline with Advanced Bio-Oil Technologies Ltd.
CARSON CITY, NV, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), announces that the signed letter of intent with Advanced Bio-oil Technologies Ltd....
Specialized Tissue Culture Company, Pharmagreen Biotech, Inc., is Featured on The Stock Day Podcast
[DATELINE]The Stock Day Podcast welcomed Pharmagreen Biotech, Inc. (OTC Pink: PHBI) ("the Company"), a company focused on the CBD hemp industry for the production and supply of starter plantlets throu...
Pharmagreen Biotech Aims to Update Its Shareholders on Company Focus on CBD Hemp Industry
CARSON CITY, NV, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc. (OTC: PHBI), a company specializing in the development of high quality tissue cultured starter plantlet...